Literature DB >> 6324897

Antidepressant withdrawal phenomena.

S C Dilsaver, J F Greden.   

Abstract

The authors review the antidepressant withdrawal literature. Withdrawal of tricyclic antidepressants may precipitate the development of discrete syndromes. The most common of these are general somatic or gastrointestinal distress with or without anxiety and agitation, sleep disturbance characterized by excessive and vivid dreaming and initial and middle insomnia, movement disorder, and psychic and behavioral activation extending on a continuum to frank mania. The etiology of these syndromes is discussed. The "cholinergic overdrive hypothesis" explains most antidepressant withdrawal phenomena, including infrequent manifestations. Some antidepressant withdrawal symptomatology may be due to an interaction between cholinergic overdrive and monoaminergic systems. A treatment program useful in ameliorating the distress of patients who develop antidepressant withdrawal symptoms and who cannot continue to take antidepressants is outlined. The theoretical significance of tricyclic withdrawal phenomena and the heuristic value of current hypotheses as to their pathophysiology are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324897

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Polypharmacy in a general surgical unit and consequences of drug withdrawal.

Authors:  J M Kennedy; A M van Rij; G F Spears; R A Pettigrew; I G Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

Review 2.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

3.  Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.

Authors:  J S Duncan; S D Shorvon; M R Trimble
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

Review 4.  Genetic and pharmacological models of cholinergic supersensitivity and affective disorders.

Authors:  D H Overstreet; R W Russell; A D Crocker; J C Gillin; D S Janowsky
Journal:  Experientia       Date:  1988-06-15

Review 5.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

6.  Clomipramine concentration and withdrawal symptoms in 10 neonates.

Authors:  Peter G J ter Horst; Susanne van der Linde; Jan Pieter Smit; Jan den Boon; Richard A van Lingen; Frank G A Jansman; Lolkje T W De Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 7.  The problems of anticholinergic adverse effects in older patients.

Authors:  M Feinberg
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

8.  Tranylcypromine withdrawal phenomena.

Authors:  M T Halle; S C Dilsaver
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

9.  Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy.

Authors:  Richard C. Shelton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

Review 10.  Withdrawal phenomena associated with antidepressant and antipsychotic agents.

Authors:  S C Dilsaver
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.